A UNIVERSITY of Ulster spin-out company is set to expand into new global markets after receiving regulatory approval for its lifesaving wireless health monitors.
Belfast-based Intelesens said its Vitalsens product has gained a CE marking, proving it has met EU consumer health and safety requirements for medical equipment.
This marking opens up new markets in Europe and South-East Asia to the firm, whose products build on sensor technologies developed by the company's founders at the University of Ulster.
The Vitalsens device is made up of a disposable electrode patch and a reusable clip-on transmitter, and offers a low-cost technology solution to help in the management of care for both chronically ill patients at home and monitoring the health of in-patients and out-patients attending hospital.
Intelesens chief executive Michael Caulfield said: "Data relating to the wearer's health, including heart rate, ecg, temperature and levels of activity are measured in the chest area and transmitted via Bluetooth to software residing on a pc or laptop in the wearer's home or in a hospital ward. This vital health information can then be accessed by medical professionals either locally or remotely, and appropriate treatments delivered rapidly."
"The next step is to gain US FDA (Food and Drug Administration) approval for the product. That will open up the enormous US market to us, taking our business - built on technology developed in Northern Ireland - to a whole new level."
Intelesens develops and manufactures its own products and also products for other equipment manufacturers and is developing a portfolio of products which aim to deliver improved quality-of-care to patients.